Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Enrolling by invitation Not applicable Interventional

Personalizing Veterans' Lung Cancer Screening and Diagnosis

ClinicalTrials.gov ID: NCT07838519

Public ClinicalTrials.gov record NCT07838519. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 24, 2026, 2:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Lung cancer screening with low-dose chest computed tomography (CT) is currently recommended for high-risk individuals who are 50 to 80 years old, have smoked cigarettes for at least 20 pack-years, and currently smoke or quit smoking within the past 15 years. In a prospective cohort at Nashville, Denver, Louisville, Chicago, Kansas City, Salisbury and Seattle Veteran Affairs medical centers, the investigators will evaluate the detection of lung cancer using an expanded screening eligibility criteria based on Veterans' personal and service-related exposures compared to standard of care criteria. Screening a larger population will increase the number of lung nodules needing clinical management and these nodules may or may not be cancer. In a population of Veterans with positive screenings at Nashville, the investigators will also validate a combination biomarker-based approach to manage screen-detected lung nodules to reduce time to lung cancer diagnosis and use of invasive procedures. This study will also convene a Veteran Community Advisory Board and interview Veterans to better understand their thoughts about lung cancer screening and preferences for outreach and engagement.

Study identification

NCT ID
NCT07838519
Recruitment status
Enrolling by invitation
Study type
Interventional
Phase
Not applicable
Enrollment
1,400 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2, 2024
Primary completion
Dec 30, 2027
Completion
Dec 30, 2027
Last update posted
Sep 23, 2026

2024 – 2027

United States locations

U.S. sites
7
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
Rocky Mountain Regional VA Medical Center, Aurora, CO Aurora Colorado 80045-7211 —
Jesse Brown VA Medical Center, Chicago, IL Chicago Illinois 60612 —
Robley Rex VA Medical Center, Louisville, KY Louisville Kentucky 40206-1433 —
Kansas City VA Medical Center, Kansas City, MO Kansas City Missouri 64128-2226 —
Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC Salisbury North Carolina 28144 —
Tennessee Valley Healthcare System Nashville Campus, Nashville, TN Nashville Tennessee 37212-2637 —
VA Puget Sound Health Care System Seattle Division, Seattle, WA Seattle Washington 98108-1532 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07838519, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 23, 2026 · Synced Sep 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07838519 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →